Data is not available at this time.
Hapbee Technologies operates in the emerging consumer wellness technology sector, developing and selling wearable devices that utilize patented ultra-low radio frequency energy technology. The company's core revenue model centers on direct sales of its Hapbee wearable device, which delivers specific low-power electromagnetic signals designed to induce various sensations including focus, relaxation, and sleep states. This positions Hapbee at the intersection of consumer electronics and digital wellness, targeting consumers seeking non-pharmacological alternatives for mood and cognitive enhancement. The company's technology represents a novel approach in the competitive wearable market, differentiating itself from conventional fitness trackers and smartwatches by focusing exclusively on neurological modulation through electromagnetic signals. Hapbee's market position is that of an early-stage innovator in a niche segment, facing the dual challenge of establishing scientific credibility while building consumer adoption for its unconventional technology platform. The company operates in a highly speculative sector where success depends on both technological validation and market acceptance of its unique value proposition.
Hapbee generated CAD $0.61 million in revenue for the fiscal period, indicating minimal commercial traction for its wearable technology products. The company reported a substantial net loss of CAD $6.60 million, reflecting significant operating expenses relative to its revenue base. Operating cash flow was negative CAD $4.27 million, demonstrating that the business is consuming substantial capital while establishing its market presence. The absence of capital expenditures suggests the company is focusing its limited resources on operational sustainability rather than infrastructure expansion.
The company's diluted EPS of -CAD $0.04 underscores its current lack of earnings power and the substantial per-share losses being incurred. With negative operating cash flow exceeding CAD $4 million, Hapbee demonstrates significant capital consumption without corresponding revenue generation. The business model currently exhibits poor capital efficiency, as evidenced by the substantial losses relative to the modest revenue base. This performance pattern is characteristic of early-stage technology companies in the pre-commercialization phase.
Hapbee maintains a constrained financial position with cash and equivalents of CAD $0.13 million, which appears insufficient to support ongoing operations given the current cash burn rate. Total debt of CAD $1.72 million represents a substantial liability relative to the company's modest asset base. The limited cash reserves coupled with significant debt obligations create considerable financial stress, likely necessitating additional financing in the near term to maintain operational continuity.
The company's current revenue level suggests it remains in the early commercialization phase, with growth trajectories yet to be established. Hapbee maintains a zero dividend policy, consistent with its developmental stage and negative earnings profile. All available capital is being directed toward funding operations and technology development rather than shareholder returns. The absence of a dividend reflects the company's priority of achieving operational sustainability before considering capital distributions.
With a market capitalization of approximately CAD $17.08 million, the valuation appears to incorporate significant speculative premium relative to current financial metrics. The low beta of 0.11 suggests limited correlation with broader market movements, potentially reflecting the company's niche focus and limited trading liquidity. Market expectations likely anticipate future technology validation and commercial success rather than current financial performance, given the substantial disparity between valuation and fundamental metrics.
Hapbee's primary strategic advantage lies in its patented electromagnetic signal technology, which represents a novel approach to wearable wellness. However, the company faces significant challenges including establishing scientific validation, achieving commercial scale, and securing adequate financing. The outlook remains highly speculative, dependent on successful technology adoption, additional funding, and demonstration of viable market demand. Near-term survival likely hinges on the company's ability to secure capital while advancing both product development and commercial initiatives.
Company filingsTSXV disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |